ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,495Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 337

$690K Total Retail Price of All Prescriptions

Rank: 30 out of 337

754 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 754 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 754 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 6,028 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
METFORMIN HCL 559 294 1 12
SIMVASTATIN 499 286 2 1
OMEPRAZOLE 455 246 3 4
AMLODIPINE BESYLATE 435 308 4 3
LISINOPRIL 385 226 5 2
ALENDRONATE SODIUM 288 238 6 19
METOPROLOL TARTRATE 271 172 7 6
HYDROCODONE-ACETAMINOPHEN 225 63 S3 8 13
TRAMADOL HCL 203 92 9 32
NAPROXEN 194 97 10 98
LISINOPRIL-HYDROCHLOROTHIAZIDE 186 118 11 31
ATORVASTATIN CALCIUM 184 130 12 7
LANTUS 159 75 13 49
INSULIN SYRINGE 151 76 14 127
NEXIUM 147 93 15 56
IBUPROFEN 145 49 16 64
LOSARTAN POTASSIUM 136 97 17 15
HYDROCHLOROTHIAZIDE 136 87 17 9
RANITIDINE HCL 133 70 19 30
GABAPENTIN 128 54 20 20
ADVAIR DISKUS 123 98 21 44
PROAIR HFA 110 69 22 38
LEVOTHYROXINE SODIUM 103 47 23 5
ATENOLOL 103 84 23 10
CITALOPRAM HBR 101 31 25 17
METOPROLOL SUCCINATE 98 72 26 21
PRAVASTATIN SODIUM 98 76 26 14
ACTOS 93 47 28 175
TAMSULOSIN HCL 91 62 29 25
ZOLPIDEM TARTRATE 90 49 30 23
JANUVIA 90 69 30 81
LOSARTAN-HYDROCHLOROTHIAZIDE 89 61 32 60
GLIMEPIRIDE 85 45 33 55
TRAZODONE HCL 85 43 33 16
GLIPIZIDE 85 66 33 45
NOVOLOG MIX 70-30 83 55 36 249
FUROSEMIDE 80 53 37 8
PANTOPRAZOLE SODIUM 76 49 38 36
CARVEDILOL 74 40 39 73
CRESTOR 73 53 40 29
AMMONIUM LACTATE 65 61 41 250
SINGULAIR 64 44 42 113
VENTOLIN HFA 62 21 43 159
CYCLOBENZAPRINE HCL 58 13 R 44 103
PREDNISONE 58 42 44 40
SPIRIVA 57 48 46 43
WARFARIN SODIUM 54 32 47 11
ENALAPRIL MALEATE 52 26 48 37
MIRTAZAPINE 52 25 48 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.